Active substanceDioxomethyltetrahydropyrimidineDioxomethyltetrahydropyrimidine
Similar drugsTo uncover
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
  • Methyluracil
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Methyluracil
    ointment externally 
    GREEN DUBRAVA, CJSC     Russia
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
    ALTAYVITAMINS, CJSC     Russia
  • Methyluracil
    suppositories rect. 
    YUZHFARM, LLC     Russia
  • Methyluracil-ACOS
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Metouracol
    sponge externally 
  • Oxolin
    ointment externally 
  • Stisamet®
    ointment locally externally 
  • Dosage form: & nbsprectal suppositories
    Composition:

    Active substance: dioxo methyl tetrahydropyrimidine (methyluracil) 500 mg.

    Excipients: solid fat (vitepsol W35 or supposir NAI25A) - 1.8 g.

    Description:Suppositories white or white with a yellowish or kremovatym shade of color, torpedo-shaped.
    Pharmacotherapeutic group:Reparation of tissue stimulant
    ATX: & nbsp

    D.11.A.X   Other preparations for the treatment of skin diseases

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    Has anabolic activity. Has hematopoietic, leukopoetic, immunostimulating, anti-inflammatory action. Nucleic normalizes metabolism, accelerates the cellular regeneration processes in the wound, accelerating the growth and maturation of the granulation tissue and epithelialization (including bystroproliferiruyuschih mucosal cells of the gastrointestinal tract), stimulates erythro- and leykopoez, cellular and humoral immunity factors.

    Indications:

    Proctitis, sigmoiditis, ulcerative colitis.

    Contraindications:

    Hypersensitivity to dioksometiltetragidropirimidinu, excipients.

    Acute and chronic forms of leukemia leukemia (particularly myeloid), lymphogranulomatosis, malignant bone marrow disease, children up to 8 years.

    Pregnancy and lactation:

    Use during pregnancy and breastfeeding possibly in case The benefit to the mother exceeds the potential risk to the fetus or child.

    Dosing and Administration:

    Rectally.

    Adults and children over 15 years - 1-2 suppository 3-4 times a day, children aged 8-15 years - 1 suppository per day. The course of treatment is from 7 days to 4 months, depending on the nature of the disease.

    Side effects:

    Allergic reactions, headache, dizziness, a brief burning sensation in the rectum.

    Overdose:

    Data on drug overdose are absent.

    Interaction:

    Not studied.

    Special instructions:

    There is no information.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to drive vehicles and other mechanisms.

    Form release / dosage:

    Suppositories rectal, 500 mg.

    Packaging:

    For 5 suppositories in a contour cell box made of a PVC / PE polymer film.

    Two contoured cells with five suppositories are placed together with the instruction for medical use of the drug in a pack of cardboard.

    Storage conditions:

    In a place protected from moisture and light, at a temperature of 2 ° C to 15 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-003991
    Date of registration:05.12.2016
    Expiration Date:05.12.2021
    The owner of the registration certificate:YUZHFARM, LLC YUZHFARM, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspYUZHFARM, LLCYUZHFARM, LLC
    Information update date: & nbsp08.05.2018
    Illustrated instructions
      Instructions
      Up